Abstract

The basis for the use of immunotherapy or biological response modifiers in acute leukaemia is the hypothesis of immune surveillance of leukaemic cells.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call